Autism Research - University of Rochester
Advertisement
The University of Rochester is the largest center for autism research in New York State and one of the largest in the United States. Neurodevelopmental and Behavioral Pediatrics has a pivotal role in this research effort. Current studies at the University of Rochester focus on screening and diagnosis of Autism related disorders. Medical identification of comorbid conditioning, the genetic basis of early brain development, identification of environmental risk factors, basic differences in neurobiology and chemosensory functioning and effects and outcomes of different types of treatments that range from intense behavioral therapies to dietary interventions.
A team of University of Rochester investigators is conducting the Children’s Hyperactivity and Autism Research Treatment Study (CHARTS) with a grant from the National Institute for Mental Health . This study focuses on the 1 in 4 children with autism who also live with symptoms of ADHD, or attention deficit hyperactivity disorder. The study will evaluate the effectiveness of two treatments. One treatment is a medication called atomoxetine (also called Strattera). This medication is intended to reduce symptoms of Attention Deficit Hyperactivity Disorder. The other treatment is called Parent Management Training (PMT). This training is intended to help parents learn how to manage their child’s challenging behaviors. The Rochester team is joined by counterparts at Ohio State University Medical Center and the University of Pittsburgh Medical Center.